Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
He is the lead author of Unintended consequences of glucagon-like peptide-1 receptor agonists medication in children and adolescents: A call to action , a commentary about the risks of weight-loss drugs for children, including an increased risk of suicidal ideation
Similar content being viewed by others Introduction Weight regain (WR) and insufficient weight loss (IWL) are significant challenges faced by 2025% of patients following bariatric surgery, often stemming from a combination of anatomical variations, genetic predispositions, hormonal imbalances, dietary noncompliance, and inadequate physical activity [1,2,3]
Patients with history of MBS are advised to consume fibre to reduce carbohydrate absorption, limit foods with a high glycemic index, prefer complex carbohydrates, and have a diet fractioned in frequent small meals [44, 47,48,49]
11.1 What GLP-1 Therapy Does Not Do Current evidence does not support the claim that GLP-1 receptor agonists: Cause universal micronutrient depletion Directly impair intestinal absorption Mimic bariatric malabsorption Require blanket supplementation Intestinal anatomy remains intact
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils
